Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
943 studies found for:    (women)[ALL-FIELDS] AND (HIV) [CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
(women)[ALL-FIELDS] AND (HIV) [CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy
Conditions: HIV Infections;   Pregnancy
Interventions: Drug: Lamivudine;   Drug: Lamivudine/Zidovudine;   Drug: Nelfinavir mesylate;   Drug: Nevirapine;   Drug: Zidovudine
2 Completed Feasibility of a Stigma Reduction Intervention for Human Immunodeficiency Virus (HIV)-Infected Women
Conditions: Human Immunodeficiency Virus (HIV);   Self-efficacy;   Self-esteem
Intervention: Behavioral: Ipod video
3 Completed Sex, Aging and Antiretroviral Pharmacokinetics
Condition: HIV Infections
Intervention: Drug: ARV regimen chosen by treating physician
4 Recruiting Brief Intervention for Rural Women at High Risk for HIV/HCV
Conditions: Acquired Immune Deficiency Syndrome Virus;   Hepatitis C;   Drug Abuse
Intervention: Other: MI-based HIV Risk Reduction
5 Completed An Intervention to Improve Antenatal Access to CD4 Testing and HAART in Botswana
Conditions: HIV Infection;   Pregnancy
Intervention: Other: Tokafatso programmatic intervention
6 Active, not recruiting HIV and Drug Use in Georgian Women
Condition: Human Immunodeficiency Virus
Interventions: Behavioral: RBT;   Other: Case-Management
7 Active, not recruiting A Retrospective Analysis of Raltegravir Use in Minority HIV Infected Women in Houston, Texas
Condition: HIV Infection
Intervention: Drug: raltegravir
8 Completed Empowerment Intervention for Young Women - Phase I
Conditions: HIV;   Empowerment;   HIV Infections
Intervention: Behavioral: Prevention Empowerment Intervention for Young Women
9 Completed Project POWER, Adapting Project SAFE: Reducing STD/HIV Risk in Women Prisoners
Condition: HIV Infections
Interventions: Behavioral: Project POWER HIV Risk-reduction Intervention;   Behavioral: NC DOC Standard of Care for STIs
10 Active, not recruiting Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women (WAVES)
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Interventions: Drug: EVG/COBI/FTC/TDF;   Drug: RTV;   Drug: ATV;   Drug: FTC/TDF;   Drug: EVG/COBI/FTC/TDF Placebo;   Drug: RTV Placebo;   Drug: ATV Placebo;   Drug: FTC/TDF Placebo
11 Recruiting Reducing the Burden of Malaria in HIV-Infected Pregnant Women and Their HIV-Exposed Children (PROMOTE-BC2)
Conditions: Malaria;   Human Immunodeficiency Virus
Interventions: Drug: Monthly dihydroartemisinin-piperaquine (DP) for adult women during pregnancy;   Drug: Monthly dihydroartemisinin-piperaquine (DP) for infants
12 Completed
Has Results
Evaluation of the Healthy Love Workshop, an HIV Prevention Intervention for African American Women
Conditions: HIV Infections;   Sexually Transmitted Infections
Interventions: Behavioral: Healthy Love Workshop;   Behavioral: HIV/AIDS 101 Workshop
13 Completed ID and Testing Via Friendship Networks
Conditions: Asymptomatic HIV;   HIV Infections
Interventions: Other: Index Recruiter;   Other: Friendship Network Member
14 Completed Safety and Effectiveness of Tenofovir 1% Gel, Tenofovir Disproxil Fumarate, and Emtricitabine/Tenofovir Disoproxil Fumarate Tablets in Preventing HIV in Women
Condition: HIV Infections
Interventions: Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Emtricitabine/tenofovir disoproxil fumarate placebo;   Drug: Tenofovir disoproxil fumarate;   Drug: Tenofovir disoproxil fumarate placebo;   Drug: Tenofovir 1% vaginal gel;   Drug: Tenofovir placebo
15 Withdrawn Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in Pregnant and Breastfeeding Women : a Phase 3 Trial
Conditions: HIV Infection;   Pregnancy;   Breastfeeding;   HIV Infections
Interventions: Drug: Efavirenz-Tenofovir-Emtricitabine;   Drug: Zidovudine-Lamivudine-Lopinavir/Ritonavir
16 Active, not recruiting WHC+ (Women's Health CoOp PLUS)
Conditions: HIV;   Sexual Risk;   Sexually Transmitted Diseases;   Substance Abuse;   Violence;   Victimization
Interventions: Behavioral: Test, Treat, Retain(TTR) + Women's Health CoOp (WHC);   Biological: Test, Treat, Retain(TTR) only
17 Unknown  Trial of Male Circumcision: HIV, Sexually Transmitted Disease (STD) and Behavioral Effects in Men, Women and the Community
Conditions: HIV Infections;   Sexually Transmitted Diseases;   Papillomavirus Infections;   Genital Herpes;   Gonorrhea;   Chlamydia Infections;   Syphilis;   Bacterial Vaginosis
Intervention: Procedure: Male circumcision
18 Enrolling by invitation A Comparison of Immediate Treatment of CIN1 With Cryotherapy and 12 Month Cytology Follow up in HIV Seropositive Women
Condition: Cervical Dysplasia
Intervention: Procedure: cryotherapy
19 Completed Safety and Pharmacokinetics of Dapivirine/Maraviroc Vaginal Ring
Condition: HIV Infections
Interventions: Drug: Dapivirine Vaginal Ring;   Drug: Maraviroc Vaginal Ring;   Other: Placebo Vaginal Ring;   Drug: Dapivirine-Maraviroc Vaginal Ring
20 Completed Pregnant Women's CoOp
Condition: HIV
Interventions: Behavioral: Woman-focused intervention;   Behavioral: Treatment as Usual

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years